Nxera Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 1,885,136 | 2.11% |
VC/PE Firms | 5,610,000 | 6.27% |
Hedge Funds | 6,368,100 | 7.12% |
Individual Insiders | 7,444,223 | 8.32% |
Institutions | 19,430,091 | 21.7% |
General Public | 48,708,892 | 54.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,630,000 | US$65.5m | -0.03% | no data | |||
6,368,100 | US$62.9m | 43.9% | 4.52% | |||
5,610,000 | US$55.4m | 0% | no data | |||
3,885,702 | US$38.4m | -12.4% | no data | |||
2,880,526 | US$28.4m | 9.39% | no data | |||
2,768,070 | US$27.3m | 165% | 0.02% | |||
2,212,300 | US$21.8m | -18% | 0.01% | |||
1,885,136 | US$18.6m | 0% | no data | |||
1,717,600 | US$17.0m | -25.1% | 0.02% | |||
1,687,300 | US$16.7m | 5.67% | 0.01% | |||
1,303,300 | US$12.9m | 0% | no data | |||
1,295,347 | US$12.8m | -5.28% | 0.01% | |||
1,208,900 | US$11.9m | 33.1% | 0.01% | |||
1,084,869 | US$10.7m | 0.02% | 0.01% | |||
991,837 | US$9.8m | 0% | 0.57% | |||
959,800 | US$9.5m | 3.76% | no data | |||
724,817 | US$7.2m | -50.1% | no data | |||
632,185 | US$6.2m | -38.7% | 0.02% | |||
594,270 | US$5.9m | -49.3% | no data | |||
166,000 | US$1.6m | 0% | no data | |||
158,500 | US$1.6m | 0% | 0.05% | |||
151,444 | US$1.5m | 6.92% | no data | |||
133,000 | US$1.3m | 32.7% | no data | |||
91,900 | US$907.3k | 62.9% | no data | |||
88,563 | US$874.3k | 0% | 0.06% |